Replies to post #7385 on Halozyme Therapeutics Inc (HALO)

[Fred Kadiddlehopper]

Thanks for posting that. I rarely have access to analyst notes ao it's interesting to see what they are focused on.
Technically the pullback/consolidation phase is fulfilled, and I'm getting ready to replenish my trading shares, which were called away at $55, for the next leg up. Helen, despite her flaws, is reliable when she openly predicts pending deals, so with three in the works, added to a likely approval of SG Egartigimod, I think it's a good bet for at least a testing of the recent highs, if not a bona fide breakout. The latter would depend on how significant the larger of the new deals turns out to be.

[Fred Kadiddlehopper]

By the way, do you know what the pps was at the time the MS note was published? I'd like to know what base line he was working with when predicting the percentage ups and downs.